Active Ingredient(s): Becaplermin, rh-PDGF
FDA Approved: * December 16, 1997
Category: Ulcer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Regranex Overview

Becaplermin (brand name Regranex & Plermin) is a cicatrizant, available as a topical gel. Regranex is a human platelet-derived growth factor indicated along with good wound care for the treatment of lower extremity diabetic neuropathic ulcers.[1] It is also known as "platelet-derived growth factor BB".[1] Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 See also 5 References 6 External links Medical uses The drug is used for the treat...

Read more Regranex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Regranex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Becaplermin, rh-PDGF
  • Gel: 0.01%, 100ug/g
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Regranex: (2 results)

Sorted by National Drug Code
  • 0064-0810 Regranex 100 ug/g Topical Gel by Healthpoint, Ltd
  • 50484-810 Regranex 100 ug/g Topical Gel by Smith & Nephew, Inc.

Other drugs which contain Becaplermin, rh-PDGF or a similar ingredient: (1 result)

Related Regranex Topics:

Regranex Gel